Business & regional news

Medtronic announced today that it recently received CE mark for its Radiant™ balloon-expandable covered stent, the first and currently only covered stent indicated for use in ChEVAR with the...

TCT 2022: Late-breaking data from Intrepid™ Pilot Study 3-year follow-up & 1-year follow-up from Transfemoral EFS study demonstrate promising valve performance Medtronic today announced new data...

TCT 2022: Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets Medtronic today announced findings from its Pathological Study of Hypo-Attenuated...

TCT 2022: Medtronic Unveils Latest Transcatheter Aortic Valve Replacement Data in Late-Breaking Clinical Science and Presentations

George Murgatroyd, general manager and vice president of Digital Surgery at Medtronic, will join Kimberly Powell, vice president of Healthcare and Life Sciences at NVIDIA, in a fireside chat at NVIDIA

Medtronic plc, a global leader in healthcare technology, announces U.S. Food and Drug Administration (FDA) 510(k) clearance for the RespArray™ patient monitor designed for procedural sedation and medical-surgical units.

Combination of InPen™ smart insulin pen system integrated with Guardian™ 4 CGM helps people with diabetes on multiple daily injections (MDI) stay ahead of their glucose levels^i,ii

Partnership enables Patient Monitoring business’ commitment to transforming health monitoring by expanding access to continuous vital sign monitoring of patients from in-hospital to home

Medtronic announced today that it has launched its newest drug-eluting coronary stent, the Onyx Frontier™ drug-eluting stent (DES), following recent CE Mark approval. The Onyx Frontier DES...

Actress Jennifer Stone, best known for her role on the Disney Channel’s “Wizards of Waverly Place”, will be partnering with Medtronic Diabetes to help others living with type 1 diabetes learn more about advanced technologies that can help make life with diabetes easier...